Report - SUDA LTD: INVESTOR PRESENTATION For personal use onlyPre-clinical *ZolpiMist Zolpidem Insomnia $2.1bn SUD-002 Ondansetron Chemotherapy induced nausea & vomiting $2.5bn SUD-005 Midazolam

Please pass captcha verification before submit form